Triamterene and Hydrochlorothiazide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Triamterene and Hydrochlorothiazide

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING



TRIAMTERENE AND HYDROCHLOROTHIAZIDE DESCRIPTION



Triamterene and Hydrochlorothiazide


Triamterene and Hydrochlorothiazide




CLINICAL PHARMACOLOGY



Triamterene


WARNINGS


Hydrochlorothiazide





INDICATIONS & USAGE

This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked.




Usage In Pregnancy



TRIAMTERENE AND HYDROCHLOROTHIAZIDE CONTRAINDICATIONS

Hyperkalemia


Antikaliuretic Therapy or Potassium Supplementation


Impaired Renal Function


Hypersensitivity


WARNINGS


Hyperkalemia






CONTRAINDICATIONS

PRECAUTIONS: Drug Interactions

Metabolic or Respiratory Acidosis


Acute Myopia and Secondary Angle-Closure Glaucoma


PRECAUTIONS


General

ELECTROLYTE IMBALANCE AND BUN INCREASES






HEPATIC COMA


RENAL STONES


FOLIC ACID DEFICIENCY


HYPERURICEMIA


METABOLIC AND ENDOCRINE EFFECTS




HYPERSENSITIVITY



DRUG INTERACTIONS







DRUG & OR LABORATORY TEST INTERACTIONS



CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY

Carcinogenesis


Triamterene



Hydrochlorothiazide


Mutagenesis


Triamterene


Hydrochlorothiazide



Impairment of Fertility


Hydrochlorothiazide


PREGNANCY

Category C

TERATOGENIC EFFECTS

Triamterene and Hydrochlorothiazide



Triamterene



Hydrochlorothiazide


NONTERATOGENIC EFFECTS


NURSING MOTHERS



PEDIATRIC USE



TRIAMTERENE AND HYDROCHLOROTHIAZIDE ADVERSE REACTIONS


Gastrointestinal:
Central Nervous System:
Cardiovascular:
Renal:
Hematologic:
Ophthalmic:
Hypersensitivity:
Other:


Altered Laboratory Findings
WARNINGSPRECAUTIONS

PRECAUTIONS
PRECAUTIONS


OVERDOSAGE




DOSAGE & ADMINISTRATION

WARNINGSWARNINGS

PRECAUTIONS: Drug Interactions


HOW SUPPLIED











STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-895(NDC:0781-1123)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
TRIAMTERENE TRIAMTERENE 37.5 mg
HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 25 mg

Inactive Ingredients

Ingredient Name Strength
MAGNESIUM STEARATE
cellulose, microcrystalline
CROSCARMELLOSE SODIUM
D&C YELLOW NO. 10
FD&C BLUE NO. 1
HYPROMELLOSE 2910 (3 MPA.S)
polysorbate 80
SODIUM BICARBONATE

Product Characteristics

Color Size Imprint Code Shape
green 8 mm GG165 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-895-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA073281 2012-03-07


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.